Literature DB >> 10221926

Chemotherapy and radiotherapy for locally advanced cervical cancer.

C Williams.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10221926      PMCID： PMC1115572          DOI： 10.1136/bmj.318.7192.1161

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix.

Authors:  C J Tseng; C T Chang; C H Lai; Y K Soong; J H Hong; S G Tang; S Hsueh
Journal:  Gynecol Oncol       Date:  1997-07       Impact factor: 5.482

2.  Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer.

Authors:  L C Wong; Y C Choo; D Choy; J S Sham; H K Ma
Journal:  Gynecol Oncol       Date:  1989-11       Impact factor: 5.482

3.  Potentiation of radiotherapy by cis-dichlorodiammine platinum (II) in advanced cervical carcinoma.

Authors:  Y C Choo; T K Choy; L C Wong; H K Ma
Journal:  Gynecol Oncol       Date:  1986-01       Impact factor: 5.482

4.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

Authors:  M Morris; P J Eifel; J Lu; P W Grigsby; C Levenback; R E Stevens; M Rotman; D M Gershenson; D G Mutch
Journal:  N Engl J Med       Date:  1999-04-15       Impact factor: 91.245

5.  Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

Authors:  P G Rose; B N Bundy; E B Watkins; J T Thigpen; G Deppe; M A Maiman; D L Clarke-Pearson; S Insalaco
Journal:  N Engl J Med       Date:  1999-04-15       Impact factor: 91.245

6.  Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.

Authors:  H M Keys; B N Bundy; F B Stehman; L I Muderspach; W E Chafe; C L Suggs; J L Walker; D Gersell
Journal:  N Engl J Med       Date:  1999-04-15       Impact factor: 91.245
  6 in total
  1 in total

1.  Long-term results and prognostic factors of patients with cervical carcinoma treated with concurrent chemoradiotherapy.

Authors:  Ana Reig; Ismael Membrive; Palmira Foro; Xavier Sanz; Núria Rodríguez; Joan Lozano; Martí Lacruz; Jaume Quera; Enric Fernández-Velilla; Manuel Algara
Journal:  Clin Transl Oncol       Date:  2011-07       Impact factor: 3.405
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.